Stock & Company Details
Celldex Therapeutics Inc. $CLDX
Price:
46,691,331
78M
$3.3B
52 Week High:
$66.15
10 Day Average Volume:
42,760,466
-20.27
50 Day Moving Average:
$156.49
52 Week Low:
$43.74
30 Day Average Volume:
49,506,373
$4.94
2021-02-05
0.95
30 Day Change:
13%
3 Month Change:
-0.32%
Health Technology
CLDX technical indicators
Latest Celldex Therapeutics Inc. (CLDX) indicator readings as of 2026-08-10.
CLDX's 14-day RSI is 75.5, in overbought territory. At $42.97 it is trading 43.0% above its 200-day moving average of $30.06, and above its 50-day average of $35.26. Price sits above the upper Bollinger Band ($32.72 to $42.59). ADX reads 29.5, indicating a trending market.
Select a strategy to see its performance
Backtested on this stock over recent history.
| Strategy | Trend | Return | Win rate |
|---|---|---|---|
| MACD Momentum Momentum Buy when MACD turns positive (crosses above zero) and RSI confirms momentum above 50; sell when MACD falls back below zero. | – | – | |
| RSI Reversal Mean reversion Buy when RSI falls below 30 (oversold), sell when it climbs above 70 (overbought). | – | – | |
| Volatility Breakout Volatility Buy when price closes above the upper Bollinger Band, sell on reversion to the 20-day average. | – | – | |
| Strong-Trend Pullback Trend + timing In strongly trending stocks (ADX above 25), buy short-term dips (Stochastic below 30) and sell into overbought (above 80). | – | – |
Overview
Celldex is a clinical stage biotechnology company dedicated to developing monoclonal and bispecific antibodies that address devastating diseases for which available treatments are inadequate. Our pipeline includes antibody-based therapeutics which have the ability to engage the human immune system and/or directly effect critical pathways to improve the lives of patients with inflammatory diseases and many forms of cancer.
Finance Bot
Ask your questions
Start by typing a question below.
